Overview
Tae-sik Park practices practicing medicine in Ka-ch'on, Republic of Korea.
Their clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Obesity, Atherosclerosis, and Maturity Onset Diabetes of the Young.
They are actively involved in clinical research, co-authoring 59 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tae-sik Park
Is Tae-sik Park a top-rated expert for Non-Alcoholic Fatty Liver Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Tae-sik Park is classified as an Experienced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tae-sik Park participate in research or clinical trials?
Yes. Tae-sik Park has published 59 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Tae-sik Park's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AtherosclerosisPark isExperienced. Learn about Atherosclerosis.
- Maturity Onset Diabetes of the Young
- Non-Alcoholic Fatty Liver Disease
- ObesityPark isExperienced. Learn about Obesity.